NKTX Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-27 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 10,050,818 | P-Purchase | A | 3,000,000 | 10.00 | 30,000,000.00 |
| 2024-03-27 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 3,000,031 | P-Purchase | A | 3,000,031 | 0.00 | 300.00 |
| 2024-03-27 | George Simeon | director | 1,548,341 | P-Purchase | A | 1,548,341 | 10.00 | 15,483,410.00 |
| 2024-03-27 | George Simeon | director | 451,659 | P-Purchase | A | 451,659 | 10.00 | 4,516,590.00 |
| 2024-03-01 | HASTINGS PAUL J | director, officer: Chief Executive Officer | 378,149 | D-Return | D | 12,358 | 13.00 | 160,654.00 |
| 2024-03-04 | HASTINGS PAUL J | director, officer: Chief Executive Officer | 240,507 | D-Return | D | 137,642 | 13.33 | 1,834,768.00 |
| 2024-03-01 | Brandenberger Ralph | officer: Chief Technical Officer | 88,339 | M-Exempt | A | 2,955 | 3.89 | 11,495.00 |
| 2024-03-01 | Brandenberger Ralph | officer: Chief Technical Officer | 85,384 | M-Exempt | A | 3,808 | 3.89 | 14,813.00 |
| 2024-03-01 | Brandenberger Ralph | officer: Chief Technical Officer | 79,972 | S-Sale | D | 8,367 | 12.51 | 104,671.00 |
| 2024-03-01 | Brandenberger Ralph | officer: Chief Technical Officer | 25,629 | M-Exempt | D | 2,955 | 3.89 | 11,495.00 |
| 2024-03-01 | Brandenberger Ralph | officer: Chief Technical Officer | 22,445 | M-Exempt | D | 3,808 | 3.89 | 14,813.00 |
| 2024-02-12 | Trager James | officer: Chief Scientific Officer | 149,415 | S-Sale | D | 4,143 | 12.00 | 49,716.00 |
| 2024-01-16 | Shook David | officer: Chief Medical Officer | 114,980 | S-Sale | D | 3,552 | 8.74 | 31,044.00 |
| 2024-01-16 | Trager James | officer: Chief Scientific Officer | 153,558 | S-Sale | D | 4,560 | 8.74 | 39,854.00 |
| 2024-01-16 | Brandenberger Ralph | officer: Chief Technical Officer | 81,576 | S-Sale | D | 2,512 | 8.74 | 21,955.00 |
| 2024-01-16 | HASTINGS PAUL J | director, officer: Chief Executive Officer | 390,507 | S-Sale | D | 9,697 | 8.74 | 84,752.00 |
| 2024-01-16 | Hager Alicia J. | officer: Chief Legal Officer | 107,942 | S-Sale | D | 4,554 | 8.74 | 39,802.00 |
| 2024-01-04 | Shook David | officer: Chief Medical Officer | 118,532 | A-Award | A | 56,000 | 0.00 | 0.00 |
| 2024-01-04 | Shook David | officer: Chief Medical Officer | 112,500 | A-Award | A | 112,500 | 6.01 | 676,125.00 |
| 2024-01-04 | Brandenberger Ralph | officer: Chief Technical Officer | 112,500 | A-Award | A | 112,500 | 6.01 | 676,125.00 |
| 2024-01-04 | Brandenberger Ralph | officer: Chief Technical Officer | 84,088 | A-Award | A | 56,000 | 0.00 | 0.00 |
| 2024-01-04 | Trager James | officer: Chief Scientific Officer | 158,118 | A-Award | A | 56,000 | 0.00 | 0.00 |
| 2024-01-04 | Trager James | officer: Chief Scientific Officer | 112,500 | A-Award | A | 112,500 | 6.01 | 676,125.00 |
| 2024-01-04 | HASTINGS PAUL J | director, officer: Chief Executive Officer | 509,500 | A-Award | A | 509,500 | 6.01 | 3,062,095.00 |
| 2024-01-04 | HASTINGS PAUL J | director, officer: Chief Executive Officer | 400,204 | A-Award | A | 85,000 | 0.00 | 0.00 |
| 2024-01-04 | Levin Alyssa | officer: See Remarks | 112,500 | A-Award | A | 112,500 | 6.01 | 676,125.00 |
| 2024-01-04 | Levin Alyssa | officer: See Remarks | 56,000 | A-Award | A | 56,000 | 0.00 | 0.00 |
| 2024-01-04 | Hager Alicia J. | officer: Chief Legal Officer | 112,500 | A-Award | A | 112,500 | 6.01 | 676,125.00 |
| 2024-01-04 | Hager Alicia J. | officer: Chief Legal Officer | 112,496 | A-Award | A | 56,000 | 0.00 | 0.00 |
| 2023-08-21 | Shook David | officer: Chief Medical Officer | 60,532 | S-Sale | D | 1,331 | 1.83 | 2,436.00 |
| 2023-07-01 | Levin Alyssa | officer: See Remarks | 442,400 | A-Award | A | 442,400 | 2.19 | 968,856.00 |
| 2023-07-01 | Levin Alyssa | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-07-01 | Shook David | officer: Chief Medical Officer | 208,000 | A-Award | A | 208,000 | 2.19 | 455,520.00 |
| 2023-06-20 | Trager James | officer: Chief Scientific Officer | 100,118 | S-Sale | D | 439 | 4.85 | 2,129.00 |
| 2023-06-20 | Brandenberger Ralph | officer: Chief Technical Officer | 28,088 | S-Sale | D | 221 | 4.85 | 1,072.00 |
| 2023-06-20 | Hager Alicia J. | officer: Chief Legal Officer | 56,496 | S-Sale | D | 701 | 4.85 | 3,400.00 |
| 2023-06-20 | Shook David | officer: Chief Medical Officer | 61,863 | S-Sale | D | 439 | 4.85 | 2,129.00 |
| 2023-06-20 | Mahmood Nadir | officer: See Remarks | 85,776 | S-Sale | D | 526 | 4.85 | 2,551.00 |
| 2023-06-20 | HASTINGS PAUL J | director, officer: Chief Executive Officer | 313,402 | S-Sale | D | 1,704 | 4.85 | 8,264.00 |
| 2023-06-07 | George Simeon | director | 22,500 | A-Award | A | 22,500 | 4.86 | 109,350.00 |
| 2023-06-07 | Behbahani Ali | director | 22,500 | A-Award | A | 22,500 | 4.86 | 109,350.00 |
| 2023-06-07 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 22,500 | A-Award | A | 22,500 | 4.86 | 109,350.00 |
| 2023-06-07 | Thedinga Angela | director | 22,500 | A-Award | A | 22,500 | 4.86 | 109,350.00 |
| 2023-06-07 | PATTERSON LEONE D | director | 22,500 | A-Award | A | 22,500 | 4.86 | 109,350.00 |
| 2023-06-07 | Dybbs Michael | director | 22,500 | A-Award | A | 22,500 | 4.86 | 109,350.00 |
| 2023-06-07 | Azzam Fouad Oscar | director | 22,500 | A-Award | A | 22,500 | 4.86 | 109,350.00 |
| 2023-06-07 | Scheiner Zachary | director | 22,500 | A-Award | A | 22,500 | 4.86 | 109,350.00 |
| 2023-01-13 | Trager James | officer: Chief Scientific Officer | 99,672 | A-Award | A | 37,500 | 0.00 | 0.00 |
| 2023-01-17 | Trager James | officer: Chief Scientific Officer | 98,557 | S-Sale | D | 1,115 | 5.49 | 6,121.00 |
| 2023-01-13 | Trager James | officer: Chief Scientific Officer | 75,000 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2023-01-13 | Shook David | officer: Chief Medical Officer | 75,000 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2023-01-13 | Shook David | officer: Chief Medical Officer | 60,477 | A-Award | A | 37,500 | 0.00 | 0.00 |
| 2023-01-17 | Shook David | officer: Chief Medical Officer | 60,302 | S-Sale | D | 175 | 5.49 | 960.80 |
| 2023-01-13 | Mahmood Nadir | officer: See Remarks | 85,424 | A-Award | A | 37,500 | 0.00 | 0.00 |
| 2023-01-17 | Mahmood Nadir | officer: See Remarks | 84,302 | S-Sale | D | 1,122 | 5.49 | 6,160.00 |
| 2023-01-13 | Mahmood Nadir | officer: See Remarks | 75,000 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2023-01-13 | HASTINGS PAUL J | officer: Chief Executive Officer | 386,500 | A-Award | A | 386,500 | 0.00 | 0.00 |
| 2023-01-13 | HASTINGS PAUL J | officer: Chief Executive Officer | 316,797 | A-Award | A | 64,500 | 0.00 | 0.00 |
| 2023-01-17 | HASTINGS PAUL J | officer: Chief Executive Officer | 313,106 | S-Sale | D | 3,691 | 5.49 | 20,264.00 |
| 2023-01-13 | Hager Alicia J. | officer: Chief Legal Officer | 75,000 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2023-01-13 | Hager Alicia J. | officer: Chief Legal Officer | 58,300 | A-Award | A | 37,500 | 0.00 | 0.00 |
| 2023-01-17 | Hager Alicia J. | officer: Chief Legal Officer | 57,197 | S-Sale | D | 1,103 | 5.49 | 6,055.00 |
| 2023-01-13 | Brandenberger Ralph | officer: Chief Technical Officer | 42,000 | A-Award | A | 42,000 | 0.00 | 0.00 |
| 2023-01-13 | Brandenberger Ralph | officer: Chief Technical Officer | 28,800 | A-Award | A | 21,000 | 0.00 | 0.00 |
| 2023-01-17 | Brandenberger Ralph | officer: Chief Technical Officer | 28,309 | S-Sale | D | 491 | 5.49 | 2,696.00 |
| 2023-01-01 | Shook David | officer: Chief Medical Officer | None | D | 30,000 | 16.46 | 493,800.00 | |
| 2023-01-01 | Shook David | officer: Chief Medical Officer | 22,977 | D | 0 | 0.00 | 0.00 | |
| 2022-10-06 | Brandenberger Ralph | officer: Chief Technical Officer | 28,584 | M-Exempt | D | 842 | 0.00 | 0.00 |
| 2022-10-06 | Brandenberger Ralph | officer: Chief Technical Officer | 8,642 | M-Exempt | A | 842 | 3.89 | 3,275.00 |
| 2022-10-06 | Brandenberger Ralph | officer: Chief Technical Officer | 7,800 | S-Sale | D | 842 | 14.02 | 11,805.00 |
| 2022-09-28 | HASTINGS PAUL J | officer: Chief Executive Officer | 250,461 | S-Sale | D | 498 | 13.00 | 6,474.00 |
| 2022-09-21 | HASTINGS PAUL J | director, officer: Chief Executive Officer | 274,335 | S-Sale | D | 6,126 | 13.01 | 79,717.00 |
| 2022-08-15 | Trager James | officer: Chief Scientific Officer | 88,243 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
| 2022-08-15 | Trager James | officer: Chief Scientific Officer | 88,243 | M-Exempt | D | 5,000 | 3.89 | 19,450.00 |
| 2022-08-15 | Trager James | officer: Chief Scientific Officer | 67,172 | M-Exempt | A | 5,000 | 3.89 | 19,450.00 |
| 2022-08-15 | Trager James | officer: Chief Scientific Officer | 62,172 | S-Sale | D | 5,000 | 17.53 | 87,656.00 |
| 2022-08-15 | Brandenberger Ralph | officer: Chief Technical Officer | 26,253 | M-Exempt | D | 11,000 | 0.00 | 0.00 |
| 2022-08-15 | Brandenberger Ralph | officer: Chief Technical Officer | 7,800 | S-Sale | D | 11,000 | 17.64 | 194,052.00 |
| 2022-08-15 | Mahmood Nadir | officer: See Remarks | 68,062 | M-Exempt | D | 2,681 | 3.89 | 10,429.00 |
| 2022-08-15 | Mahmood Nadir | officer: See Remarks | 53,588 | M-Exempt | A | 7,500 | 3.89 | 29,175.00 |
| 2022-08-15 | Mahmood Nadir | officer: See Remarks | 46,088 | S-Sale | D | 7,500 | 18.03 | 135,215.00 |
| 2022-08-15 | Mahmood Nadir | officer: See Remarks | 27,703 | M-Exempt | D | 4,819 | 3.89 | 18,746.00 |
| 2022-08-15 | Mahmood Nadir | officer: See Remarks | 27,703 | M-Exempt | D | 4,819 | 0.00 | 0.00 |
| 2022-08-08 | Brandenberger Ralph | officer: Chief Technical Officer | 19,053 | M-Exempt | A | 6,886 | 3.89 | 26,787.00 |
| 2022-08-08 | Brandenberger Ralph | officer: Chief Technical Officer | 7,800 | S-Sale | D | 11,593 | 15.51 | 179,783.00 |
| 2022-08-08 | Mahmood Nadir | officer: See Remarks | 53,588 | M-Exempt | A | 7,500 | 3.89 | 29,175.00 |
| 2022-08-08 | Mahmood Nadir | officer: See Remarks | 46,088 | S-Sale | D | 7,500 | 15.32 | 114,900.00 |
| 2022-08-08 | Mahmood Nadir | officer: See Remarks | 32,522 | M-Exempt | D | 7,500 | 3.89 | 29,175.00 |
| 2022-07-25 | Brandenberger Ralph | officer: Chief Technical Officer | 7,800 | S-Sale | D | 3,000 | 13.41 | 40,230.00 |
| 2022-07-25 | Brandenberger Ralph | officer: Chief Technical Officer | 4,367 | M-Exempt | D | 3,000 | 0.00 | 0.00 |
| 2022-07-25 | Mahmood Nadir | officer: See Remarks | 63,243 | M-Exempt | D | 7,500 | 3.89 | 29,175.00 |
| 2022-07-25 | Mahmood Nadir | officer: See Remarks | 53,588 | M-Exempt | A | 7,500 | 3.89 | 29,175.00 |
| 2022-07-25 | Mahmood Nadir | officer: See Remarks | 46,088 | S-Sale | D | 7,500 | 13.40 | 100,480.00 |
| 2022-07-15 | Brandenberger Ralph | officer: Chief Technical Officer | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-17 | HASTINGS PAUL J | officer: Chief Executive Officer | 280,461 | A-Award | A | 19,500 | 0.00 | 0.00 |
| 2022-06-17 | HASTINGS PAUL J | director, officer: Chief Executive Officer | 120,000 | A-Award | A | 120,000 | 12.25 | 1,470,000.00 |
| 2022-06-17 | Mahmood Nadir | officer: See Remarks | 46,088 | A-Award | A | 6,000 | 0.00 | 0.00 |
| 2022-06-17 | Mahmood Nadir | officer: See Remarks | 40,000 | A-Award | A | 40,000 | 12.25 | 490,000.00 |
| 2022-06-17 | Hager Alicia J. | officer: Chief Legal Officer | 50,500 | A-Award | A | 50,500 | 12.25 | 618,625.00 |
| 2022-06-17 | Hager Alicia J. | officer: Chief Legal Officer | 20,800 | A-Award | A | 8,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
